Gut bacteria supplement may tame type 1 diabetes inflammation

NCT ID NCT07585994

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking a probiotic called Desulfovibrio piger for 4 weeks can lower inflammation and help preserve the body's own insulin production in people who have had type 1 diabetes for more than 5 years. Twenty adults with remaining beta cell function will receive either the probiotic or a placebo. The goal is to see if this supplement can improve immune and metabolic health, not to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam UMC

    RECRUITING

    Amsterdam, 1105 AZ, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Diabeter Centrum Amsterdam

    RECRUITING

    Amsterdam, 1066 EC, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••